Apr 13, 2021 09:33 PM IST

Marico Q4 PAT seen up 11.3% YoY to Rs. 223.9 cr: ICICI Direct

Net Sales are expected to increase by 22.6 percent Y-o-Y (down 7.8 percent Q-o-Q) to Rs. 1,834.7 crore, according to ICICI Direct.

Marico Q4 PAT seen up 12% YoY to Rs 232.4 cr: Sharekhan

Net Sales are expected to increase by 22.3 percent Y-o-Y (down 13.8 percent Q-o-Q) to Rs 1,829.3 crore, according to Sharekhan.

Marico: Growth strong, but input pressure mars the show in Q4

Parachute’s position as a market leader should help Marico corner a significant share of this market

Marico expects to deliver low double-digit bottomline growth in Q4

Marico said in the last quarter of the previous fiscal, the FMCG sector continued to exhibit improving demand trends as quarterly economic growth has moved into positive territory and the COVID-19 vaccination rollout gathered pace.

Marico declares interim dividend of Rs 4.50 per share

"The board of directors of the company at its meeting… approved the declaration of second interim equity dividend for the financial year 2020-21 of Rs 4.50 per equity share of Rs 1 each, being 450 percent on the paid-up equity share capital of Rs 129.13 crore,” Marico said in a regulatory filing.

Buy Marico; target of Rs 490: ICICI Direct

ICICI Direct is bullish on Marico has recommended buy rating on the stock with a target price of Rs 490 in its research report dated January 29, 2021.

Accumulate Marico; target of Rs 440: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Marico with a target price of Rs 440 in its research report dated January 28, 2021.

Buy Marico; target of Rs 490: Motilal Oswal

Motilal Oswal is bullish on Marico has recommended buy rating on the stock with a target price of Rs 490 in its research report dated January 28, 2021.

Buy Marico; target of Rs 477: Sharekhan

Sharekhan is bullish on Marico has recommended buy rating on the stock with a target price of Rs 477 in its research report dated January 28, 2021.

Accumulate Marico; target of Rs 440: Dolat Capital Market

Dolat Capital Market recommended accumulate rating on Marico with a target price of Rs 440 in its research report dated January 28, 2021.

Marico eyes Rs 100 crore revenue from Saffola honey in FY22: Report

On January 28, Marico reported a 13.04 percent year-on-year increase in consolidated net profit to Rs 312 crore for the quarter ended December 31, 2020.

Marico: Growth across all categories, outlook continues to remain positive

After a healthy growth in value-added hair oil in the December quarter, Marico expects to capitalise on its position and sustain a double-digit growth trajectory over the medium term

Marico Standalone December 2020 Net Sales at Rs 1,667.00 crore, up 16.25% Y-o-Y

Marico Consolidated December 2020 Net Sales at Rs 2,122.00 crore, up 16.34% Y-o-Y

Consumers may have to fork out more as FMCG firms look to pass on price hikes

FMCG players are feeling the pressure to protect their gross margins as they are unlikely to absorb the surging commodity prices of key raw materials like coconut oil, edible oil, and palm oil for long.

Buy Marico; target of Rs 477: Sharekhan

Sharekhan is bullish on Marico has recommended buy rating on the stock with a target price of Rs 477 in its research report dated December 15, 2020.

This week in FMCG: Honey adulteration controversy continues; CSE vs FSSAI, firms launch sugar-free products

NMR is the advance technology to detect adulteration in honey with sugar syrups by molecular separation and identification. It is the only test that can detect the new modified ‘Chinese sugar’ being used to adulterate honey.

Dabur, Marico in spat over claims on honey, approach ASCI against each other

Marico had filed a complaint before the ASCI on October 1, over Dabur's claims of NMR of its honey and was upheld by the regulator.

Marico makes foray into plant protein category with launch of Saffola Mealmaker Soya Chunks

The firm has ventured into segments such as honey and into the ayurvedic segment with the Saffola Immuniveda range of Kadha Mix and Golden Turmeric Milk Mix and Saffola Arogyam Chyawan Amrut.

Interview | I would expect food to grow at 50 percent every quarter from now on, says Marico’s Saugata Gupta

Marico has emerged stronger from the Covid-19 crisis and is on track to attain 8-10 percent volume growth in the second half of the current fiscal year, says Saugata Gupta, MD and CEO

Buy Marico; target of Rs 440: ICICI Direct

ICICI Direct is bullish on Marico recommended buy rating on the stock with a target price of Rs 440 in its research report dated October 29, 2020.

Accumulate Marico; target of Rs 407: Arihant Capital

Arihant Capital recommended accumulate rating on Marico with a target price of Rs 407 in its research report dated October 30, 2020.

COVID-19: Marico, Dabur, and Amul hit the market with more ayurvedic products

With government guidelines advising people to consume turmeric and giloy to prevent infection, demand for ayurvedic products have increased. FMCG firms like Marico, Dabur, and Amul have already jumped into the fray and announced a slew of launches.

Buy Marico; target of Rs 420: Sharekhan

Sharekhan is bullish on Marico has recommended buy rating on the stock with a target price of Rs 420 in its research report dated October 28, 2020.

Buy Marico; target of Rs 440: Motilal Oswal

Motilal Oswal is bullish on Marico recommended buy rating on the stock with a target price of Rs 440 in its research report dated October 29, 2020.